Immune Pharmaceuticals secures funding of up to USD21.5m from institutional investors
Immune Pharmaceuticals Inc has secured financings of up to USD21.5 million through two financing agreements. The first, with Hercules Technology Growth Capital, for a term loan of up to USD9.5 million. The second agreement, with mutual fund Discover Growth Fund, for the sale to Discover of newly created Series D


